KDM6A and cancer: Importantly, while KDM6A mutations are relatively rare in HNSCC [47], we observed significantly elevated KDM6A-pSer829 levels in clinical specimens, suggesting that post-translational modification represents a predominant mechanism of KDM6A regulation in this cancer type [47].